1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 27 APRIL 2015

Cancer Drug News 27 APRIL 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Celgene's Haematology Expertise Will Benefit AstraZeneca
Industry Brief - Halaven Launched In UAE For MBC
Industry Brief - Arzerra Phase III Study Meets Primary Endpoint Of PFS In Relapsed CLL
Industry Brief - MedImmune/Juno Enter Immuno-Oncology Trial Collaboration
Industry Trend Analysis - Pfizer Cannot Rely Solely On Resurrecting Shelved Oncology Candidates To Drive Growth
Industry Brief - Onconova Submits Rigosertib Trial Protocol To FDA/EMA In Higher-Risk MDS
Industry Brief - FDA Accepts Adcetris sBLA; Grants Priority Review For HL Following ASCT
Industry Brief - Pomalyst Meets Accelerated Approval Requirements For r/r MM
Industry Brief - Ono Seeks Japanese Approval For Additional Indication Of Opdivo
Industry Brief - Xalkori Gains FDA Breakthrough Therapy Designation For ROS1-Positive NSCLC
Industry Trend Analysis - AstraZeneca Will Continue To Increase Oncology Segment's Strength
Industry Brief - ARIAD Granted US Patent Covering Brigatinib
Industry Trend Analysis - Genomic Profiling Expanding Utility Of Targeted Drugs
Industry Brief - Nymox' NX-1207 Phase II Trial Improves Outcomes In PCA
Industry Brief - Dosing Begins In Demcizumab Phase II Trial For First-Line MPC
Industry Brief - Oasmia's Paclical Approved In Russia
Industry Brief - CanTx' Cantrixil Gains FDA ODD For OC
Industry Brief - Lilly's Cyramza Gains Fourth FDA Approval
Industry Brief - FDA Grants ODD To SolaranRx' SRX-1177 For Late-Stage Malignant Melanoma
Industry Brief - CHMP Adopts Positive Opinion On Opdivo For Advanced Melanoma
Industry Trend Analysis - Immuno-Oncology Market Will Become Crowded As Focus Increases
Industry Brief - Batu Granted US Patent Covering ImmXcyte
Industry Brief - Curadev/Roche Enter Cancer Immunotherapy Deal
Industry Trend Analysis - GSK Oncology Additions To Increase Novartis' Growth Trajectory
Industry Brief - AbbVie Extends Exchange Offer To Acquire Pharmacyclics

Table Of Contents

Cancer Drug News 27 APRIL 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.